PRAK Inhibitors
Researchers utilize PRAK inhibitors in biochemical and cellular studies to investigate the physiological and pathological roles of PRAK in cellular signaling, without reference to drug applications. The design and development of these inhibitors rely on a comprehensive understanding of PRAK's structural features and its involvement in cellular responses to stress, inflammation, and cellular growth, providing valuable tools for advancing research in the field of cellular signaling and kinase regulation.
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Rottlerin | 82-08-6 | sc-3550 sc-3550B sc-3550A sc-3550C sc-3550D sc-3550E | 10 mg 25 mg 50 mg 1 g 5 g 20 g | $84.00 $166.00 $302.00 $2091.00 $5212.00 $16657.00 | 51 | |
Rottlerin (CAS 82-08-6) is a natural chemical compound derived from Mallotus philippinensis. It acts as an inhibitor of PRAK (p38-regulated/activated protein kinase), a member of the MAPK family. By targeting PRAK, Rottlerin modulates cellular signaling pathways involved in stress responses, apoptosis, and cell differentiation. Its specific interaction with PRAK makes it a valuable tool in research to investigate the roles of this kinase in various cellular processes. | ||||||
CID 755673 | 521937-07-5 | sc-205246 | 10 mg | $203.00 | 1 | |
CID 755673 (CAS 521937-07-5) is a chemical compound known for its inhibitory effects on PRAK (p38-regulated/activated protein kinase), a member of the MAPK family. By selectively targeting PRAK, CID 755673 interferes with cellular signaling pathways involved in stress responses, apoptosis, and cell differentiation. Its specific inhibition of PRAK makes it a valuable tool in scientific research to investigate the functions and roles of this kinase in various cellular processes. | ||||||
MK-2 Inhibitor III | 1186648-22-5 | sc-221948 | 5 mg | $400.00 | 3 | |
MK-2 Inhibitor III (CAS 1186648-22-5) is a chemical compound that acts as an inhibitor of PRAK (p38-regulated/activated protein kinase). By selectively targeting PRAK, MK-2 Inhibitor III interferes with cellular signaling pathways involved in stress responses, inflammation, and cell proliferation. Its specific inhibition of PRAK makes it a valuable tool in scientific research to study the functions and roles of this kinase in various cellular processes. | ||||||
Caffeine | 58-08-2 | sc-202514 sc-202514A sc-202514B sc-202514C sc-202514D | 50 g 100 g 250 g 1 kg 5 kg | $33.00 $67.00 $97.00 $192.00 $775.00 | 13 | |
Caffeine has been reported to inhibit PRK activity in certain cellular contexts. | ||||||
Paullone | 142273-18-5 | sc-208152 | 10 mg | $260.00 | 2 | |
Certain paullone derivatives have been studied for their inhibitory effects on PRK and other kinases. | ||||||
SB 203580 | 152121-47-6 | sc-3533 sc-3533A | 1 mg 5 mg | $90.00 $349.00 | 284 | |
SB203580 is a well-known inhibitor of p38 MAPK, which can also affect PRK activity. | ||||||
Luteolin | 491-70-3 | sc-203119 sc-203119A sc-203119B sc-203119C sc-203119D | 5 mg 50 mg 500 mg 5 g 500 g | $27.00 $51.00 $101.00 $153.00 $1925.00 | 40 | |
Luteolin is a natural flavonoid compound that has been reported to inhibit PRK activity. | ||||||
Doramapimod | 285983-48-4 | sc-300502 sc-300502A sc-300502B | 25 mg 50 mg 100 mg | $149.00 $281.00 $459.00 | 2 | |
BIRB 796 is a potent inhibitor of p38 MAPK, which can also affect PRK activity. | ||||||
PKF118-310 | 84-82-2 | sc-364590 sc-364590A | 5 mg 25 mg | $180.00 $651.00 | ||
PKF 118-310 is a pyrazolo[1,5-a]pyrimidine compound that has been studied for its inhibitory effects on PRK and other kinases. | ||||||